BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Clinical trial NCT02872259 · COMPLETED
Trial details
- NCT number
- NCT02872259
- Sponsor
- Haukeland University Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2024-05-23
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.